Expansion of KPC-producing Klebsiella pneumoniae with various mgrB mutations giving rise to colistin resistance: the role of ISL3 on

被引:34
|
作者
Giordano, Cesira [1 ]
Barnini, Simona [1 ]
Tsioutis, Constantinos [2 ,3 ]
Chlebowicz, Monika A. [4 ]
Scoulica, Effie V. [3 ]
Gikas, Achilleas [3 ]
Rossen, John W. [4 ]
Friedrich, Alexander W. [4 ]
Bathoorn, Erik [4 ]
机构
[1] Azienda Osped Univ Pisana, Bacteriol Unit, Via Paradisa 2, I-56124 Pisa, Italy
[2] Univ Hosp Heraklion, Infect Dis Unit, Dept Internal Med, Iraklion 71110, Crete, Greece
[3] European Univ Cyprus, Sch Med, 6 Diogenis St, CY-1516 Nicosia, Cyprus
[4] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Hanzepl 1,Hpc EB80, NL-9713 GZ Groningen, Netherlands
关键词
KPC; Colistin; Klebsiella pneumoniae; Molecular epidemiology; mgrB; ISL3; NOSOCOMIAL OUTBREAK; EMERGENCE; CARBAPENEMASES; EPIDEMIOLOGY; INFECTIONS; GENE;
D O I
10.1016/j.ijantimicag.2017.10.011
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
mcr-1 has been reported as the first plasmid-encoded gene conferring colistin resistance. In KPC-producing Klebsiella pneumoniae (KPC-KP), however, colistin resistance is rapidly emerging through other mechanisms. Resistance is frequently due to disruption of the mgrB gene by insertion sequences, e.g. ISL3. The aim of this study was to investigate the expansion of mgrB-mutated KPC-KP isolates. In addition, the localisation and targets of ISL3 sequences within the core and accessory genome of common KPC-KP lineages were identified. A total of 29 clinical K. pneumoniae isolates collected from Italian patients were randomly selected. Whole genome sequences were analysed for resistance genes, plasmids and insertion sequences. In addition, 27 colistin-resistant KPC-KP isolates from a previous study from Crete (Greece) were assessed. Clonal expansion of KPC-KP isolates with various mutations in mgrB among all lineages was observed. In two Italian MLST ST512 isolates and eight Greek ST258 isolates, an identical copy of ISL3 was inserted in mgrB nucleotide position 133. ISL3, a transposable restriction-modification system of 8154 nucleotides, was located on pKpQIL-like plasmids and may transpose into the chromosome. In four isolates, chromosomal integration of ISL3 in diverse inner membrane proteins other than mgrB was identified. Colistin resistance is most often explained by clonal expansion of isolates with mutated mgrB. pKpQIL-like plasmids, which are omnipresent in KPC-KP, carry insertion sequences such as ISL3 that have mgrB as a target hotspot for transposition. Transposition of insertion sequences from plasmids and subsequent clonal expansion may contribute to the emerging colistin resistance in KPC-KP. (c) 2017 The Authors. Published by Elsevier B.V.
引用
收藏
页码:260 / 265
页数:6
相关论文
共 50 条
  • [21] Ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae accompanied hypermucoviscosity acquisition
    Guo, Yingyi
    Wang, Jiong
    Yao, Likang
    Wang, Yijing
    Zhang, Yan
    Zhuo, Chuyue
    Yang, Xu
    Li, Feifeng
    Li, Jiahui
    Liu, Baomo
    He, Nanhao
    Chen, Jiakang
    Xiao, Shunian
    Lin, Zhiwei
    Zhuo, Chao
    BMC MICROBIOLOGY, 2024, 24 (01):
  • [23] Colistin Resistance Caused by Inactivation of the MgrB Regulator Is Not Associated with Decreased Virulence of Sequence Type 258 KPC Carbapenemase-Producing Klebsiella pneumoniae
    Arena, Fabio
    De Angelis, Lucia Henrici
    Cannatelli, Antonio
    Di Pilato, Vincenzo
    Amorese, Marina
    D'Andrea, Marco Maria
    Giani, Tommaso
    Rossolini, Gian Maria
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (04) : 2509 - 2512
  • [24] In Vitro Mechanisms of Resistance Development to Imipenem-Relebactam in KPC-Producing Klebsiella pneumoniae
    Findlay, Jacqueline
    Rens, Celine
    Poirel, Laurent
    Nordmann, Patrice
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (10)
  • [25] Impact of various conditions on the efficacy of dual carbapenem therapy against KPC-producing Klebsiella pneumoniae
    Wiskirchen, Dora E.
    Crandon, Jared L.
    Nicolau, David P.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 41 (06) : 582 - 585
  • [26] Easy synergism for colistin-resistant KPC-producing Klebsiella pneumoniae: the E-test with supplemented agar
    Tagliaferri, E.
    Tascini, C.
    Leonildi, A.
    Ciullo, I.
    Amadori, F.
    Menichetti, F.
    CLINICAL MICROBIOLOGY AND INFECTION, 2015, 21 (02) : E7 - E8
  • [27] Detection of ISEcp1-associated blaCTX-M-15-mediated resistance to colistin in KPC-producing Klebsiella pneumoniae isolates
    Ferreira, Melina Lorraine
    Goncalves, Iara Rossi
    Araujo, Bruna Fuga
    Royer, Sabrina
    Campos, Paola Amaral
    da Fonseca Batistao, Deivid William
    Cerdeira, Louise Teixeira
    de Brito, Cristiane Silveira
    Gontijo-Filho, Paulo P.
    Ribas, Rosineide Marques
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2018, 51 (05) : 810 - 811
  • [28] High-level cefiderocol and ceftazidime/avibactam resistance in KPC-producing Klebsiella pneumoniae associated with mutations in KPC and the sensor histidine kinase EnvZ
    Findlay, Jacqueline
    Bianco, Gabriele
    Boattini, Matteo
    Nordmann, Patrice
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2025,
  • [29] The Effect of β-Lactam Antibiotics on the Evolution of Ceftazidime/Avibactam and Cefiderocol Resistance in KPC-Producing Klebsiella pneumoniae
    Zhang, Ping
    Hu, Huangdu
    Shi, Qiucheng
    Sun, Long
    Wu, Xueqing
    Hua, Xiaoting
    McNally, Alan
    Jiang, Yan
    Yu, Yunsong
    Du, Xiaoxing
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023, 67 (03)
  • [30] Prevalence and mechanisms of fosfomycin resistance among KPC-producing Klebsiella pneumoniae clinical isolates in China
    Huang, Lin
    Cao, Min
    Hu, Yanyan
    Zhang, Rong
    Xiao, Yufei
    Chen, Gongxiang
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2021, 57 (01)